Bruker Spatial Biology provides best‑in‑class solutions for capturing the full complexity of biology through a portfolio of instruments, software, and services.
Heading to #EACR2026? Join us in Budapest. Bruker Spatial Biology is bringing high fidelity, multiomic insights to cancer research, enabling researchers to capture the full complexity of disease biology. 📌 Meet us at booth #49
https://t.co/rqajqlnwBd
#CancerReseach
🌌 Galaxy Spatial Tour is coming to Seoul and Tokyo! Join us and capture the full complexity of biology. RSVP today!
Seoul (Jun 2nd)
https://t.co/QLVEGeAMb6
Tokyo (Jun 4th)
https://t.co/QH8MuZbGI9
#GalaxySpatialTour#SpatialBiology
🧬 Researchers from the University of South Alabama, integrated clinical, transcriptomic, and proteomic data to investigate ethnic disparities in breast cancer across Gulf Coast populations. Read the poster 🔗 https://t.co/A0zvAcjoLu #BreastCancer#Multiomics#Oncology
🌸 Double the Biology, Half the Price. This spring, unlock deeper biological insight and save 50% on combined RNA + protein assays for the nCounter® Analysis System through June 19. 👉 More information: https://t.co/kUXq9XKeOw
#Multiomics#FFPE#GeneExpression
📍 We’ll be at ISCO 2026! See you at ISCO on May 28–29 - let’s talk innovation, data, and the future of spatial biology at the Diagnostica Longwood booth 👉 https://t.co/aB0rBqRAdH
#SingleCell#Omics#SpatialBiology
What if segmentation errors in spatial transcriptomics could be minimized? With 3D AI‑driven segmentation in AtoMx®, CosMx® SMI overcomes long-standing limitations by reconstructing cells in 3D—delivering improved accuracy in complex tissues. Learn more 👉 https://t.co/E5HGunp62A
The European leg of the Galaxy Spatial Tour is officially wrapped!📍From Luxembourg to Oslo, Regensburg, and Glasgow—thank you to our incredible speakers and attendees for the inspiring exchanges. Stay tuned for the next stops of the tour
🌍 https://t.co/d3acI00bTG
🔬Your protein analysis is only as reliable as the antibodies driving it. With Abcam, we developed a multi-step validation pipeline to ensure every antibody in nCounter® protein panels meets strict criteria for specificity, sensitivity & reproducibility.📄 https://t.co/o2nk00JeFp
A recent independent study published in Nature evaluated imaging-based #spatialtranscriptomics platforms in inflammatory bowel disease (IBD) tissues, CosMx SMI demonstrated higher detection efficiency than Xenium across commercially available panels. 🔗 https://t.co/Uxa2rvMNy2
Recent advances highlighted in Nature describe how spatial multi-omics is being applied to complex tissues to connect cellular identity, state, and function within intact biological FFPE samples, enabling more complete and clinically relevant insights. 🔗 https://t.co/59sDIuAvix
Join our latest webinar to explore a unified workflow combining GeoMx® DSP for spatial multiomic discovery with CellScape™ XR for single-cell protein validation on the same tissue section. Save your seat! https://t.co/uFqZnvlKhX
"What are the determinants of response to immunotherapy in GI cancers? Can we identify patient response biomarkers and better stratify them?" - Mennatallah G. Addressing these questions requires deeper, spatially resolved insight into tumor biology - leveraging CosMx® SMI.
Li, Y., Wei, C., Yang, W. et al. Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials. Nat Commun (2026). https://t.co/SyxJBTF2SR. Licensed under a Creative Commons Attribution 4.0 International License.
Using ulcerative colitis and Crohn’s disease FFPE samples, researchers from Northwestern University compared CosMx SMI and Xenium, across several matched tissue blocks, overlapping gene sets, and assays, assessing the biological utility and scalability for clinical FFPE samples.
This independent comparative and spatial biology study delivers a clear conclusion: CosMx SMI delivers unmatched sensitivity, accuracy, and biological discovery for spatial transcriptomics.
Last month, we had the privilege of hosting a successful multi-city roadshow across India. Each session brought together an exceptional group of professionals, fostering meaningful discussions around best-in-class solutions for capturing the full complexity of biology.
For the first time, knit together live T‑cell function with spatial biology in the tumor microenvironment. The result: deeper insight into tumor immunity and clearer paths to next‑generation, patient‑specific immunotherapies. Check out our AACR poster: 👉 https://t.co/Y5yzCJX9f0
📺 Now Available On Demand: Introducing the CellScape™ XR Platform. Missed the live session? You can now watch our webinar on your schedule and explore the next generation of multiplexed spatial proteomics. 👉 https://t.co/QbpHaG02fM